{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:25:40Z","timestamp":1790040340814,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Pediatric Emergency Medicine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.cpem.2012.09.005","type":"journal-article","created":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T15:24:40Z","timestamp":1354375480000},"page":"300-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Adverse Effects and Toxicity of the Atypical Antipsychotics: What Is Important for the Pediatric Emergency Medicine Practitioner?"],"prefix":"10.1016","volume":"13","author":[{"given":"J.J.","family":"Rasimas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Liebelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpem.2012.09.005_bb0005","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archpedi.158.8.753","article-title":"New users of antipsychotic medications among children enrolled in TennCare","volume":"158","author":"Cooper","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.cpem.2012.09.005_bb0010","series-title":"Your child does not have bipolar disorder: how bad science and good public relations created the diagnosis","author":"Kaplan","year":"2011"},{"key":"10.1016\/j.cpem.2012.09.005_bb0015","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3109\/15563650.2011.635149","article-title":"2010 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th annual report","volume":"49","author":"Bronstein","year":"2011","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.cpem.2012.09.005_bb0020","first-page":"161","article-title":"Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action","volume":"25","author":"Kapur","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.cpem.2012.09.005_bb0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/cap.2007.0061","article-title":"QT interval and dispersion in very young children treated with antipsychotic drugs: a retrospective chart review","volume":"17","author":"Nahshoni","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.cpem.2012.09.005_bb0030","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.2008.08050756","article-title":"Double-blind comparison of the first- and second-generation antipsychotics in early-onset schizophrenia and schizoaffective disorder: findings from the treatment of early onset schizophrenia spectrum disorders (TEOSS) study","volume":"165","author":"Sikich","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.cpem.2012.09.005_bb0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/11585350-000000000-00000","article-title":"Management of schizophrenia in children and adolescents. Focus on pharmacotherapy","volume":"71","author":"Masi","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.cpem.2012.09.005_bb0040","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2165\/11592020-000000000-00000","article-title":"Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Pringsheim","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.cpem.2012.09.005_bb0045","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archpsyc.1996.01830120020005","article-title":"Childhood onset schizophrenia: a double-blind clozapine-haloperidol comparison","volume":"53","author":"Kumra","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.cpem.2012.09.005_bb0050","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/cap.2006.0117","article-title":"One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review","volume":"17","author":"Correll","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.cpem.2012.09.005_bb0055","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second generation antipsychotic medications during first time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cpem.2012.09.005_bb0060","first-page":"687","article-title":"QTc prolongation by psychotropic drugs and the risk of torsade de pointes","volume":"108","author":"Wenzel-Seifert","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.cpem.2012.09.005_bb0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14740338.7.2.181","article-title":"Sudden cardiac death secondary to anti-depressant and antipsychotic drugs","volume":"7","author":"Sicouri","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.cpem.2012.09.005_bb0070","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpem.2012.09.005_bb0075","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1517\/14656566.9.12.2053","article-title":"Child and adolescent schizophrenia: pharmacological approaches","volume":"9","author":"Madaan","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cpem.2012.09.005_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.chi.0000145372.61239.bb","article-title":"Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study","volume":"44","author":"Blair","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.cpem.2012.09.005_bb0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/cap.2011.0024","article-title":"Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study","volume":"21","author":"Correll","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.cpem.2012.09.005_bb0095","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1592\/phco.20.13.1092.35036","article-title":"Therapeutic options in the treatment of clozapine-induced sialorrhea","volume":"20","author":"Rogers","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cpem.2012.09.005_bb0100","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1176\/appi.ajp.163.2.204","article-title":"Myocarditis during clozapine treatment","volume":"163","author":"Merrill","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.cpem.2012.09.005_bb0105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ajem.2008.04.020","article-title":"A systematic review of cardiovascular effects following atypical antipsychotic medication overdose","volume":"27","author":"Tan","year":"2009","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cpem.2012.09.005_bb0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0196-0644(99)70249-0","article-title":"Olanzapine overdose mimicking opioid intoxication","volume":"34","author":"O'Malley","year":"1999","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cpem.2012.09.005_bb0115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/PEC.0b013e31819e3775","article-title":"Pediatric ziprasidone overdose","volume":"25","author":"Fasano","year":"2009","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.cpem.2012.09.005_bb0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1081\/CLT-53097","article-title":"Aripiprazole (Abilify\u2122) overdose in a child","volume":"43","author":"Seifert","year":"2005","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.cpem.2012.09.005_bb0125","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1176\/appi.ajp.2008.07101574","article-title":"Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study","volume":"165","author":"Gr\u00fcnder","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.cpem.2012.09.005_bb0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1081\/CLT-53095","article-title":"Atypical experience: a case series of pediatric aripiprazole exposures","volume":"43","author":"Lofton","year":"2005","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.cpem.2012.09.005_bb0135","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/PEC.0b013e3181f39d5b","article-title":"Prolonged delirium after quetiapine overdose","volume":"26","author":"Rhyee","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.cpem.2012.09.005_bb0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.annemergmed.2010.10.015","article-title":"Paliperidone overdose with delayed onset of toxicity","volume":"58","author":"Levine","year":"2011","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cpem.2012.09.005_bb0145","first-page":"13","article-title":"Trends in antipsychotic drug use by very young, privately insured children","volume":"49","author":"Olfson","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.cpem.2012.09.005_bb0150","first-page":"162","article-title":"Paradoxical and severe hypotension in response to adrenaline infusions in massive quetiapine overdose: the case for lipid rescue","volume":"11","author":"Grace","year":"2009","journal-title":"Crit Care Resusc"}],"container-title":["Clinical Pediatric Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1522840112000766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1522840112000766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:28:55Z","timestamp":1761499735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1522840112000766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1522840112000766"],"URL":"https:\/\/doi.org\/10.1016\/j.cpem.2012.09.005","relation":{},"ISSN":["1522-8401"],"issn-type":[{"value":"1522-8401","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse Effects and Toxicity of the Atypical Antipsychotics: What Is Important for the Pediatric Emergency Medicine Practitioner?","name":"articletitle","label":"Article Title"},{"value":"Clinical Pediatric Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpem.2012.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}